Literature DB >> 7762677

Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungs.

F Grimminger1, N Weissmann, R Spriestersbach, E Becker, S Rosseau, W Seeger.   

Abstract

The involvement of NADPH oxidase in hypoxic pulmonary vasoconstriction (HPV) was investigated in buffer-perfused rabbit lungs, employing the inhibitors diphenyleneiodonium (DPI) and apocynin. Responses to the vasoconstrictors U-46619 and angiotensin II (ANG II) were used to test specificity. Lung nitric oxide (NO) generation was assessed by on-line monitoring of NO exhalation (chemiluminescence), and the efficacy of DPI and apocynin on the NADPH oxidase-dependent O2- generation was quantified in alveolar macrophages by fluorescent-activated cell sorter technique. In a concentration range between 1 and 5 mM, apocynin inhibited macrophage respiratory burst and HPV but similarly suppressed U-46619-induced vasoconstrictor responses. DPI inhibited macrophage O2- generation in concentrations > or = 0.5 microM. At doses between 0.5 and 1.5 microM, DPI blocked lung NO generation, thereby increasing HPV. At higher doses (4 microM), in contrast, DPI fully blocked the hypoxia-induced pressor responses, whereas the vasoconstrictor responses to U-46619 and [Asn1, Val5] ANG II were not diminished. In the presence of NG-monomethyl-L-arginine, used to block lung NO generation throughout, DPI exhibited only the monophasic selective inhibition of HPV. We conclude that apocynin lacks specificity for HPV, but DPI, in addition to inhibiting lung NO generation, causes selective blockade of the hypoxia-induced vasoconstriction. This finding supports the hypothesis that an NADPH oxidase is involved in hypoxia sensing or specific signal transduction events underlying HPV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762677     DOI: 10.1152/ajplung.1995.268.5.L747

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  NADPH oxidases-do they play a role in TRPC regulation under hypoxia?

Authors:  Monika Malczyk; Christine Veith; Ralph T Schermuly; Thomas Gudermann; Alexander Dietrich; Natascha Sommer; Norbert Weissmann; Oleg Pak
Journal:  Pflugers Arch       Date:  2015-10-01       Impact factor: 3.657

Review 2.  Mitochondrial complex III: an essential component of universal oxygen sensing machinery?

Authors:  Navdeep S Chandel
Journal:  Respir Physiol Neurobiol       Date:  2010-08-11       Impact factor: 1.931

3.  Role of ROS signaling in differential hypoxic Ca2+ and contractile responses in pulmonary and systemic vascular smooth muscle cells.

Authors:  Yong-Xiao Wang; Yun-Min Zheng
Journal:  Respir Physiol Neurobiol       Date:  2010-08-14       Impact factor: 1.931

Review 4.  Hypoxia-induced changes in pulmonary and systemic vascular resistance: where is the O2 sensor?

Authors:  Gregory B Waypa; Paul T Schumacker
Journal:  Respir Physiol Neurobiol       Date:  2010-08-14       Impact factor: 1.931

5.  Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation.

Authors:  Gregory B Waypa; Jeremy D Marks; Robert D Guzy; Paul T Mungai; Jacqueline M Schriewer; Danijela Dokic; Molly K Ball; Paul T Schumacker
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

Review 6.  ROS-dependent signaling mechanisms for hypoxic Ca(2+) responses in pulmonary artery myocytes.

Authors:  Yong-Xiao Wang; Yun-Min Zheng
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

7.  Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells.

Authors:  Rakesh Rathore; Yun-Min Zheng; Chun-Feng Niu; Qing-Hua Liu; Amit Korde; Ye-Shih Ho; Yong-Xiao Wang
Journal:  Free Radic Biol Med       Date:  2008-06-21       Impact factor: 7.376

8.  Mechanisms involved in the early increase of serotonin contraction evoked by endotoxin in rat middle cerebral arteries.

Authors:  Raquel Hernanz; Maria J Alonso; Ana M Briones; Elisabet Vila; Ulf Simonsen; Mercedes Salaices
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 9.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

Review 10.  Lung oxidative damage by hypoxia.

Authors:  O F Araneda; M Tuesta
Journal:  Oxid Med Cell Longev       Date:  2012-08-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.